March 1, 2022
  • Cigna announced it plans to invest $450 million in its venture capital arm as part of its strategy to increase the company’s shareholder value and deliver long-term growth. The company will focus on contributing to bolt-on or tuck-in acquisitions along with investments in early-stage companies in the areas of insights and analytics, digital health and experience, and care delivery and enablement. Cigna’s venture arm now has seven venture capital partners and 15 existing direct investments, including Arcadia, Babyscripts, Cricket Health, Ginger, Omada and RecoveryOne. The company also plans to spend $1.25 billion in capital expenditures to fund industry innovations. (Press release here)